An Overview Of The Future Impact Of Artificial Intelligence On Community Pharmacist Services In Patient Care

Artificial Intelligence (AI) is a field of study that encompasses machine learning of intelligence, especially intelligent computer programs that generate results similar to human cognitive processes. The process normally involves gathering data, validating that the data can be used in useful ways, presenting exact or approximate conclusions, correcting, and making changes. AI is often used to learn about machine learning so the computers can do things people do. Better interpretations and more accurate analyses are made using AI technology. From this point of view, the AI technology is a fusion of computer intelligence and a number of useful statistical models ^[1]. Artificial intelligence (AI) has emerged as a sophisticated technology in several sectors, including healthcare, with the potential to revolutionize drug research and enhance pharmacy procedures. The evolution of algorithms that can learn, adapt, automate procedures and carry out complex data analysis supports the use of AI, paving the way for better operational efficiency and decision-making ^[2].

Artificial intelligence (AI) has become a more dependable and helpful tool for a variety of applications, especially in healthcare. It can help doctors practice more effectively and efficiently, which will improve patient care and results. AI can increase patients' access to care, which will probably result in better patient satisfaction and follow-up. But like other technology developments, AI has a lot of drawbacks and possible hazards that need to be fully understood and resolved before it can be relied upon to be further incorporated into healthcare ^[3]. AI has huge consequences for home pharmacy apps, offering users a number of benefits. Users can get drug information, dosage and usage guidelines, and medical advice from the comfort of their homes because of AI-integrated pharmacy apps. This can be especially useful for people living in far locations or those with physical disabilities. AI may also examine a user’s medical history and assist in creating personalised drugs regimens, including dosage, frequency, and timing to make sure users are taking their drugs properly and efficiently ^[4].

ARTIFICIAL INTELLIGENCE IN HEALTHCARE:

Over the last 50 years, the development of AI in healthcare has led to major advances in many areas of medicine. On the other hand, the growth of machine learning (ML) and deep learning (DL) has made personalised medicine possible rather than relying on methods. AI has affected clinical decision making, disease diagnosis, clinical, diagnostic, rehabilitative, surgical and prognostic procedures significantly. This improvement in AI technology has allowed for improved diagnostic accuracy, reduced physician workflow, better clinical operation efficiency, disease and treatment monitoring, accurate operations and ultimately, better patient outcomes^[5]

ROLE OF AI IN IMPROVING PATIENT CARE AND TREATMENT:

Artificial intelligence is playing an increasing role in improving patient care in community pharmacies through increased accuracy, safety and efficiency. Pharmacists can leverage technologies such as machine learning and clinical decision support systems to detect drug interactions, contraindications, and dosing errors to prevent adverse medication events and increase the safety of prescriptions ^[6,7]. AI further facilitates precision medicine by analysing patient safety data to improve medication administration and clinical outcomes ^[8]. AI also supports patient engagement and medication adherence. Mobile applications such as Medisafe can help patients with chronic diseases such as diabetes mellitus and hypertension by providing tracking features and reminders to help them adhere to their treatment plans ^[9,10]. AI-based tools make pharmacy operations such as inventory management, early risk detection, and patient counselling more efficient. Overall, AI is improving community pharmacies as a more effective, patient-centered health care provider ^[11].

ETHICAL GOVERNANCE AND TRUST:

Ethical governance and trust in artificial intelligence (AI) are important to ensure safe, responsible and patient-centered use of digital technologies in community pharmacies. Ethical governance offers formal frameworks to inform AI design and use, focusing on patient safety, accountability, data protection, fairness, and truthfulness to ensure AI is a decision-support tool and does not replace pharmacist clinical judgement. Governance frameworks also highlight the importance of continuous monitoring of AI systems after their deployment to detect errors, performance errors, and undesired clinical issues in order to guarantee long-term safety in pharmacy practice ^[12].

AI may help to detect drug interaction, dispensing decision, patient’s counselling and monitoring of medication adherence in community pharmacy practice. However, chemists need to critically assess the output of AI as these systems may not be fully transparent and require clinical validation. Moreover, workforce training and digital literacy are necessary to ensure that chemists can safely and successfully interpret AI generated advice in their daily work ^[13].

For AI to be accepted by patients and chemists, system dependability, data security, explainability and the ability of AI technologies to improve healthcare quality without adding bias or danger are all needed. Moreover, public trust is built when AI systems perform consistently, obtain regulatory approval, and are overseen by humans in transparent healthcare decision-making processes ^[14].

OPPORTUNITIES FOR COMMUNITY PHARMACIES:

Digital and artificial intelligence can allow community chemists to transform patient care in myriad ways. First, they can be used to help with medication adherence, which is a huge problem in the medical field. AI can analyse patient data to see whether patients are taking their medicine and then recommend treatment options. Digital tools are being used today to send reminders about medication, educational materials and alerts about repeat prescriptions. In addition, with patient consent it may soon be easier to collect and analyse large amounts of patient data to learn more about medicine use, side effects and treatment results. This information could be used to improve patient safety, and provide targeted therapies to improve patient’s health outcomes ^[15]. It was already used by the users to help them write, e.g. to simplify text. It was also used for health care issues around pharmacokinetics and missed doses. “It was also used to assist with marketing and website design ^[16].

Artificial intelligence (AI) presents a number of important opportunities to improve day-to-day operations in community pharmacies. It can improve drug safety by promptly identifying potential drug-drug interactions, dosage errors and contraindications which may be overlooked in routine inspections. AI also increases workflow efficiency by automating tedious tasks like inventory management and prescription filling, freeing up pharmacists to spend more time on direct patient care. Furthermore, AI enables more personalized patient counseling by analyzing patient data and identifying drug adherence patterns and specific treatment needs ^[13]. AI combined with expert judgement generally improves clinical decision making and increases the efficacy and quality of pharmacy services.

THREATS TO COMMUNITY PHARMACIES:

Through the introduction of new technology, there are often concerns about the potential loss of jobs. This has also been seen in previous technological developments. It could automate some systems without any human intervention. In fact, AI could even allow non-pharmacists and patients to sort and analyze data that qualified pharmacists use to make recommendations, such as the Good guidelines, removing the need for them to speak with pharmacists ^[16].

Artificial intelligence (AI) has the potential to benefit community pharmacies, but there are some serious issues to address. One concern is that pharmacists might start to depend too much on the AI suggestions, which could gradually diminish their confidence and awareness in making independent clinical judgements. There are also concerns over security of patient data as AI systems deal with a lot of sensitive health data that needs to be adequately safeguarded against abuse or cyber-attacks. Then there's the problem of imbalances in AI systems, where the technology couldn't always provide equally accurate guidance for all patient groups ^[12,13,16].

RECENT CHANGES

Expansion of Clinical Decision Support Systems (CDSS):

Artificial intelligence has brought evolution to clinical decision making especially with its integration in CDSS. These AI-based solutions provide the pharmacists with real-time, data-driven and patient-specific recommendations that enhance pharmaceutical safety, therapeutic efficacy and workflow efficiency ^[17,18]. AI-CDSS has several key features such as intelligence and user friendliness. It is not a new burden that takes a lot of time and effort to understand. Rather it is designed from the start to be a " intelligent The effect of AI-CDSS adoption on the rational use of clinical medicine has been the subject of an increasing number of studies in recent years ^[18].

Growth of Telepharmacy and Digital Health:

Telepharmacy, a branch of telehealth, was created in the late 1990s to address difficulties encountered in delivering pharmaceutical care in communities with limited resources. The basis is the use of telecommunications to provide remote access to pharmacist knowledge and thus resolving inequalities in the provision of healthcare. Tele pharmacy has been employed worldwide with varying degrees of success. Developed countries such as Australia and Canada have incorporated telepharmacy projects into their national healthcare systems to ensure equitable access. The COVID-19 pandemic has resulted in the introduction of tele pharmacy services worldwide and has shown the potential of tele pharmacy to provide continuously pharmaceutical care in case of emergencies. Technologies like video conferencing, electronic prescriptions and AI-powered systems have helped to boost the efficiency and reliability of telepharmacy ^[19]

Automation of Dispensing and Workflow:

Traditional manual prescription dispensing no longer meets the standards of modern pharmacy services because of its high repetitive workload, low efficiency, frequent dispensing errors, and long patient wait times. Consequently, automatic medicine dispensing systems are one of the most wanted smart devices of the last years in big community pharmacies.

Pharmacogenomics and Personalized Medicine:

Artificial intelligence is bringing improvements to health care through the promotion of specific medicine, a strategy that departs from general treatment regimens to medicines adapted to the specific characteristics of each patient. This development enables more accurate, effective, and secure health care approaches by taking into account personal differences in genetics, medical history, lifestyle, and real-time clinical information.

AI INTEGRATION IN PATIENT CARE: DIAGNOSTIC ACCURACY & IMAGING

In patient care, AI has significantly boosted diagnostic accuracy, especially in diagnostic imaging, through the use of advanced algorithms like machine learning and deep learning. These AI systems have a good performance in image analysis, being able to detect subtle anomalies in X-rays, CT scans and MRIs that would be otherwise missed by human observers, thus reducing diagnostic error and improving consistency ^[20]. Large-scale reviews have shown that AI algorithms can perform on equal with or better than expert clinicians, especially when it comes to complex pattern recognition, classification and segmentation of medical images . AI-powered imaging tools also help to speed up diagnostic workflows and allow for early disease detection, which is important for better patient outcomes and adapted treatment plans. However, despite these benefits, hurdles such as the need for robust validation, data quality, and data integration into clinical workflows, continue to be major barriers to widespread adoption ^[21]. In summary, AI algorithms are making diagnostic imaging more accurate, efficient and patient-centred in modern healthcare.

DRUG DISCOVERY & CLINICAL TRIALS:

Artificial intelligence (AI) is transforming drug development and clinical trials, enabling faster and more precise identification of therapeutic targets through data-driven methods. In early drug discovery, AI combines large-scale biological data sets such as genomes, proteomics, and disease networks to identify new targets and predict drug–target interactions with more accuracy than conventional techniques, saving time and money, as well as increasing success rates. These approaches give us the opportunity to move from hypothesis driven to predictive, systems-level modeling, where targets are prioritized based on biological importance and potential for clinical benefit.Artificial intelligence also enhances the efficiency of clinical trials by employing machine learning models to analyze multimodal data (e.g., clinical records, biomarkers, and omics profiles) to detect homogeneous patient subgroups that are more likely to respond to specific drugs. This biomarker-based classification improves the chance of positive outcomes and reduces the heterogeneity of the population and increases the design of the trials. Furthermore, AI facilitates the development of adaptive and personalized trial designs, as predictive modeling of treatment response and side effects is feasible. The synergy of these developments creates an integrated pipeline in which AI links clinical validation to target identification, thus accelerating the development of efficient and personalized therapies ^[22].

AI-DRIVEN DRUG DISCOVERY:

The AI-driven drug discovery is an important change in the pharmaceutical research by using machine learning, deep learning and large-scale biomedical data to accelerate and optimize the traditionally slow and expensive drug development process. Recent literature suggests that AI enables key processes, including target identification, de novo molecular design, virtual screening, and prediction of pharmacokinetic and toxicity properties, with improved efficiency and reduced failure rates in early-stage discovery ^[23]. Also, it allows for drug repurposing and better clinical trial design via data-driven patient stratification and real-time monitoring

 Moreover, the progress reported in Nature shows how AI combines with chemical computation and genomics to drive small-molecule development such as multi-parameter optimization and immune-targeted therapies, especially precision oncology ^[24]. Although these transformative capabilities of AI have shown promise, challenges such as data quality, model interpretability and regulatory integration still pose critical barriers, suggesting that AI significantly accelerates drug discovery but does not replace traditional experimental validation.

ROBOTIC-ASSISTED SURGERY WITH AI:

Robotic-assisted surgery (RAS) powered by artificial intelligence (AI) represents a major step forward in surgical practice, employing robotic platforms and intelligent algorithms to enhance accuracy, decision-making, and patient outcomes. Recent studies have emphasised the potential of artificial intelligence (AI) to offer real-time intraoperative guidance through tissue recognition, image analysis, and predictive modelling, assisting surgeons to make more precise and data-driven decisions intraoperatively in complex procedures ^[25]. In addition to automating some surgical activities like suturing, AI driven robotic systems provide continuous feedback and skill assessment based on surgical video and kinematic data, improving training and performance.

Moreover, studies show that AI-aided robotic surgery brings clinical benefits such as improved surgical precision, shorter operation time and complications, and personalized surgical planning with predictive analytics and digital twins.

Despite these developments, there are still major obstacles such as high implementation costs, data dependency, ethical issues and the need for strong clinical validation, which continue to be significant challenges. This points to AI being used as an augmentative tool that adds to surgeon expertise instead of replacing it in robotically assisted procedures ^[26].

REMOTE MONITORING AND VIRTUAL ASSISTANTS:

Artificial intelligence has opened a new era in healthcare, in which digital solutions are becoming progressively essential to patient care. AI-enabled virtual health care assistants and remote patient monitoring have been recognised as breakthrough innovations that enable automated support, real-time medical treatments and ongoing health surveillance. Remote patient monitoring (RPM) helps to reduce the burden on hospitals and improve patient outcomes by allowing the continuous collection and analysis of patient data outside of traditional healthcare settings. Virtual healthcare assistants also enhance patient engagement through automated support using Chabot’s, voice assistants, and AI-based diagnostic tools. Remote patient monitoring (RPM) is a fast-growing field in healthcare that uses flexible materials for wearable sensors and aims to offer physicians additional support to provide care in a variety of general hospital medical and surgical wards. Some of the benefits of remote patient monitoring include early and real-time illness detection, the ability to continuously monitor patients, preventing the worsening of illnesses and premature deaths, lowering hospitalisation costs, obtaining more accurate readings while allowing patients to engage in their regular daily activities, improving healthcare service efficiency through the use of communication technology, emergency medical care, care for patients with mobility issues, emergency care for traffic accidents and other injuries. A remote monitoring system consists of four basic elements: end terminal, data processing system, data collecting system and communication network of the hospital ^[18,19]

ARTIFICIAL INTELLIGENCE TRANSFORMING THE PATIENT CARE:

The use of artificial intelligence as a virtual tool is growing in several countries around the world. AI has revolutionized industries, increased productivity and created new opportunities because of its capacity to simulate human thinking. In the last few years, governments have adopted a number of intelligent applications that use artificial intelligence (AI) and its subsets to make predictions and recommendations in a number of industries such as social media, healthcare, finance, agriculture, education, and data security. Healthcare systems globally face problems of increasing patient demand, labour shortages and rising costs. One revolutionary technology that can help solve these problems is artificial intelligence (AI). The AI systems have the ability to analyse large volumes of medical data, aid doctors in decision making and improve the efficacy and quality of patient treatment. Artificial intelligence (AI) use in patient care has significantly One of its most important uses is early diagnosis and disease detection, where AI-powered algorithms analyse medical imaging, such as MRIs, CT scans, x-rays to detect diseases like cancer, heart disease and neurological disorders early. Another important area is robotic surgery where AI-assisted solutions increase surgical accuracy, minimize human errors and accelerate recovery ^[3]

AI-POWERED PATIENT CARE ASSISTANTS:

Artificial intelligence (AI) is transforming the healthcare industry. The impact of AI in patient care is also gaining popularity, an area that is not receiving the same attention as drug discovery, diagnostics and personalised medicine. AI-powered chatbots and virtual assistants are becoming a game changer, offering patients 24/7 access to information, education, and assistance. Traditional methods of delivering healthcare often fail to provide comprehensive and accessible services ^[16]

ETHICAL AND SAFE IMPLEMENTATION:

Ethical standards are the basis for safe healthcare delivery and for the protection of patients’ rights and well-being. Autonomy is about making informed decisions, beneficence and non-maleficence are about doing the most good and avoiding the most harm. Justice means fairness. Accountability and transparency mean we can trust our health systems. AI can be a very useful tool for community pharmacy, but must be used responsibly and carefully. Patient safety, protecting personal health information and ensuring chemists remain in control of clinical decisions must always be the focus. AI can help with things like checking drug interactions, better medication adherence and inventory control, but it should only support, not substitute for professional judgement. And it’s also important that these systems are transparent, free from discrimination and used in line with data protection laws so patients can trust them. Ultimately, chemists are fully responsible for patient care and AI systems should be regularly reviewed to ensure they are safe and effective^[11]

CONCLUSION

In conclusion, artificial intelligence is changing the community pharmacy and healthcare industries by providing creative solutions that raise patient care quality, efficiency, and accuracy. Its ability to handle many of the present issues facing healthcare systems, such as growing patient demands and resource constraints, is demonstrated by its incorporation into fields including medicinal products safety, personalized medicine, telepharmacy, and drug development. With specific therapies and digital tools, AI technologies help pharmacists make better clinical decisions, lower drug mistakes, and increase patient involvement. However, resolving important issues including data security, ethical issues, system accessibility, and the requirement to reduce discrimination in AI algorithms is necessary for the effective implementation of AI. In order for healthcare personnel to use these technologies effectively, they also need to be properly trained and knowledgeable about technology.

Most importantly, AI should serve as a helpful tool that improves pharmacists' clinical judgment and professional responsibilities rather than taking their place. To guarantee patient safety and uphold confidence in healthcare systems, human oversight is still crucial. AI has the ability to improve overall health outcomes by creating a more effective, accessible, and patient-focused healthcare environment with responsible implementation, ongoing monitoring, and effective regulatory frameworks.

REFERENCES

1. Raza MA, Aziz S, Noreen M, et al. Artificial intelligence (AI) in pharmacy: an overview of innovations. Innov Pharm. 2022;13(2):13. doi:10.24926/iip.v13i2.4839.
2. Allam H. Prescribing the future: the role of artificial intelligence in pharmacy. Information. 2025;16(2):131. doi:10.3390/info16020131.
3. Hirani R, Noruzi K, Khuram H, et al. Artificial intelligence and healthcare: a journey through history, present innovations, and future possibilities. Life. 2024;14(5):557. doi:10.3390/life14050557.
4. Khan O, Parvez M, Kumari P, Parvez S, Ahmad S. The future of pharmacy: how AI is revolutionizing the industry. Intell Pharm. 2023;1(1):32-40.
5. Chalasani SH, Syed J, Ramesh M, Patil V, Pramod Kumar TM. Artificial intelligence in the field of pharmacy practice: a literature review. Explor Res Clin Soc Pharm. 2023;12:100346. doi:10.1016/j.rcsop.2023.100346.
6. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44-56.
7. Bates DW, Gawande AA. Improving safety with information technology. N Engl J Med. 2003;348(25):2526-2534. doi:10.1056/NEJMsa020847.
8. Ashley EA. Towards precision medicine. Nat Rev Genet. 2016;17(9):507-522. doi:10.1038/nrg.2016.86.
9. Santo K, et al. Mobile phone apps to improve medication adherence. J Med Internet Res. 2019.
10. Sabaté E. Adherence to long-term therapies. Geneva: World Health Organization; 2003.
11. Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94-98. doi:10.7861/futurehosp.6-2-94.
12. World Health Organization. Ethics and governance of artificial intelligence for health: WHO guidance. Geneva: World Health Organization; 2021.
13. European Commission. Ethics guidelines for trustworthy AI. Brussels: Directorate-General for Communications Networks, Content and Technology; 2019 Apr 8.
14. Char DS, Shah NH, Magnus D. Implementing machine learning in health care—addressing ethical challenges. N Engl J Med. 2018;378(11):981-983.
15. Crilly P. Opportunities and threats for community pharmacy in the era of enhanced technology and artificial intelligence. Int J Pharm Pract. 2023;31(5):447-448.
16. De Ruiter EJ, Eimermann VM, Rijcken C, Taxis K, Borgsteede SD. The extent and type of use, opportunities and concerns of ChatGPT in community pharmacy: a survey of community pharmacy staff. Explor Res Clin Soc Pharm. 2025;17:100575.
17. Alam A, Shah SS, Rabbani SA, El-Tanani M. The role of artificial intelligence in pharmacy practice and patient care: innovations and implications. BioMedInformatics. 2025;5(4):65. doi:10.3390/biomedinformatics5040065.
18. Chen X, Jin P, Mai H, et al. Artificial intelligence in pharmaceutical administration and clinical pharmacy: a comprehensive review of advancements, challenges, and future directions. Intell Pharm. Published online April 2026. doi:10.1016/j.ipha.2026.04.003.
19. Awala EV, Olutimehin D. Revolutionizing remote patient care: the role of machine learning and AI in enhancing tele-pharmacy services. World J Adv Res Rev. 2024;24(3):1133-1149. doi:10.30574/wjarr.2024.24.3.3831.
20. Khalifa M, Albadawy M. AI in diagnostic imaging: revolutionising accuracy and efficiency. Comput Methods Programs Biomed Update. 2024;5:100146. doi:10.1016/j.cmpbup.2024.100146.
21. Sabri O, Al-Shargabi B, Abuarqoub A. The role of artificial intelligence in improving diagnostic accuracy in medical imaging: a review. CMC. 2025;85(2):2443-2486. doi:10.32604/cmc.2025.066987.
22. Malheiro V, Santos B, Figueiras A, Mascarenhas-Melo F. The potential of artificial intelligence in pharmaceutical innovation: from drug discovery to clinical trials. Pharmaceuticals. 2025;18(6):788. doi:10.3390/ph18060788.
23. Zhang Y, Mastouri M, Zhang Y. Accelerating drug discovery, development, and clinical trials by artificial intelligence. Med. 2024;5(9):1050-1070. doi:10.1016/j.medj.2024.07.026.
24. Sutanto H, Fetarayani D. Integrating artificial intelligence into small molecule development for precision cancer immunomodulation therapy. NPJ Drug Discov. 2025;2(1):25.
25. Wah JNK. The rise of robotics and AI-assisted surgery in modern healthcare. J Robot Surg. 2025;19(1):311. doi:10.1007/s11701-025-02485-0.

Thakre D, Patel J. The advancements and benefits of AI-assisted robotic surgery. In: Proceedings of the 2024 2nd DMIHER International Conference on Artificial